New director at Meggitt
Haluk Durudogan has to taken over as President of Meggitt Aircraft Braking Systems, replacing Ken Schwartz who left to pursue private ventures.
Haluk Durudogan has to taken over as President of Meggitt Aircraft Braking Systems, replacing Ken Schwartz who left to pursue private ventures.
Chief Executive of the aerospace and defence engineering firm, Terry Twigger, said: "Ken Schwartz led our aircraft braking systems division successfully through integration and transformation. He hands over to Luke a world-leading business and a highly skilled MABS team with many exciting growth opportunities ahead of them."
The move follows what Credit Suisse described as a "week of negative newsflow for three of the group's key military platforms: F-35 JSF, Black Hawk helicopter & Eurofighter." Together, the three account for around 8% of Meggitt's revenues.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The Pentagon has binned plans to increase its order for the F-35 in fiscal 2013 and has deferred helicopter upgrades. Meanwhile, the Eruofighter loss in India has been confirmed.
"Defence growth guidance looks optimistic. Eurofighter, F-35 and Black Hawk are all platforms in which growth was expected to offset defence weakness elsewhere," the broker asserted. "We remain cautious on Meggitt's guidance of ~2% medium-term military growth, especially following what we expect to be an unusually strong 2011 for the group's defence business," Credit Suisse said, as it reiterated its under-perform expectation for Meggitt.
Despite Credit Suisse's note, Meggitt's share price rose 0.41% to 364.5p by 13:38.
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Investing in pharmaceutical companies? The pipeline is key
A strong pipeline is all-important for pharmaceutical companies. We highlight the most interesting candidates.
By Dr Mike Tubbs Published
-
RICS: Property sales rise as interest rates fall and stamp duty hike looms
Estate agents are feeling bullish about the market, with house prices forecast to rise over the next three months. But difficulties continue to mount for renters
By Ruth Emery Published